Lakeshore Biopharma Ltd (LSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LSB | AZN | AMGN | GILD | BMY |
| Company | Lakeshore Biopharma Ltd | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.7899 | 189.15 | 346.00 | 131.54 | 58.86 |
| High | 0.8500 | 189.94 | 347.66 | 132.32 | 59.21 |
| Low | 0.5743 | 187.56 | 342.52 | 129.28 | 58.35 |
| Latest | 0.6270 | 189.75 | 344.55 | 130.40 | 58.71 |
| Change | -0.1635 | -2.55 | -4.07 | -3.24 | -0.31 |
| % Change | -20.68% | -1.33% | -1.17% | -2.42% | -0.53% |
| Volume | 942,200 | 2,388,277 | 2,201,100 | 5,965,800 | 6,822,838 |
| 20-Day Average Volume | 83,840 | 1,930,685 | 2,456,105 | 5,270,975 | 9,516,940 |
| Previous Close | 0.7905 | 192.30 | 348.62 | 133.64 | 59.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8121 | 199.35 | 348.88 | 137.65 | 59.14 |
| 20-Day Raw Stochastic | 17.24% | 11.09% | 38.92% | 8.18% | 29.77% |
| 20-Day Relative Strength | 32.95 | 42.91 | 44.28 | 35.95 | 49.10 |
| Weighted Alpha | -84.30 | +32.35 | +21.12 | +21.37 | +26.06 |
| Today's Opinion | 100% Sell | 48% Buy | 8% Buy | 8% Buy | 48% Buy |
| Previous Opinion | 100% Sell | 64% Buy | 24% Buy | 24% Buy | 48% Buy |
| Last Month's Opinion | 88% Sell | 56% Buy | 56% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -24.50% since 09/12/25 | -7.35% since 04/17/26 | -3.03% since 04/17/26 | -5.26% since 04/17/26 | -2.43% since 04/17/26 |
| Low | 0.5743 on 09/19/25 | 187.56 on 04/24/26 | 340.06 on 04/21/26 | 129.28 on 04/24/26 | 57.79 on 04/21/26 |
| High | 0.8750 on 09/15/25 | 203.37 on 04/20/26 | 356.90 on 04/20/26 | 138.54 on 04/20/26 | 60.12 on 04/20/26 |
| 1-Month | |||||
| %Chg | -23.54% since 08/19/25 | +2.14% since 03/24/26 | -1.11% since 03/24/26 | -5.58% since 03/24/26 | +2.30% since 03/24/26 |
| Low | 0.5743 on 09/19/25 | 182.79 on 03/26/26 | 335.06 on 04/07/26 | 129.28 on 04/24/26 | 57.22 on 04/15/26 |
| High | 0.8799 on 09/11/25 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -32.58% since 06/18/25 | +2.07% since 01/23/26 | -0.06% since 01/23/26 | -4.07% since 01/23/26 | +7.43% since 01/23/26 |
| Low | 0.5743 on 09/19/25 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 129.28 on 04/24/26 | 54.21 on 01/29/26 |
| High | 1.4800 on 07/08/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -68.33% since 03/19/25 | +13.91% since 10/24/25 | +18.09% since 10/24/25 | +7.82% since 10/24/25 | +33.95% since 10/24/25 |
| Low | 0.5743 on 09/19/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 2.8000 on 03/21/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 13,021 | 298,239,616 | 188,144,976 | 165,876,912 | 120,503,200 |
| Shares Outstanding, K | 20,767 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 85,670,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -13,930,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 23,820,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -11,550,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.56 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 01/22/24 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 10/30/25 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.27 | 15.83 | 16.31 | 9.56 |